JP2010508071A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010508071A5 JP2010508071A5 JP2009534709A JP2009534709A JP2010508071A5 JP 2010508071 A5 JP2010508071 A5 JP 2010508071A5 JP 2009534709 A JP2009534709 A JP 2009534709A JP 2009534709 A JP2009534709 A JP 2009534709A JP 2010508071 A5 JP2010508071 A5 JP 2010508071A5
- Authority
- JP
- Japan
- Prior art keywords
- composite material
- polymer phase
- mixing
- poly
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002131 composite material Substances 0.000 claims description 65
- 229920000642 polymer Polymers 0.000 claims description 51
- 239000002904 solvent Substances 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- 239000007787 solid Substances 0.000 claims description 19
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000919 ceramic Substances 0.000 claims description 12
- 229920001577 copolymer Polymers 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 8
- 239000001506 calcium phosphate Substances 0.000 claims description 8
- 235000011010 calcium phosphates Nutrition 0.000 claims description 8
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 8
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 8
- 229920001610 polycaprolactone Polymers 0.000 claims description 8
- 239000004632 polycaprolactone Substances 0.000 claims description 8
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 4
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 4
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 4
- 230000008468 bone growth Effects 0.000 claims description 3
- 230000010072 bone remodeling Effects 0.000 claims description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims description 3
- 238000007634 remodeling Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229940035676 analgesics Drugs 0.000 claims description 2
- 239000000730 antalgic agent Substances 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 229940041181 antineoplastic drug Drugs 0.000 claims description 2
- 230000009969 flowable effect Effects 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 3
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 3
- 229960002855 simvastatin Drugs 0.000 description 3
- 239000004568 cement Substances 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85590406P | 2006-10-31 | 2006-10-31 | |
| PCT/US2007/023014 WO2008054794A2 (en) | 2006-10-31 | 2007-10-31 | Polymer-ceramic composite and method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010508071A JP2010508071A (ja) | 2010-03-18 |
| JP2010508071A5 true JP2010508071A5 (enExample) | 2010-12-16 |
Family
ID=39344908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009534709A Withdrawn JP2010508071A (ja) | 2006-10-31 | 2007-10-31 | ポリマー−セラミック複合材および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100041770A1 (enExample) |
| EP (1) | EP2086604A2 (enExample) |
| JP (1) | JP2010508071A (enExample) |
| KR (1) | KR20090091710A (enExample) |
| CN (1) | CN101600462A (enExample) |
| AU (1) | AU2007314268A1 (enExample) |
| BR (1) | BRPI0718068A2 (enExample) |
| CA (1) | CA2668265A1 (enExample) |
| CO (1) | CO6190540A2 (enExample) |
| WO (1) | WO2008054794A2 (enExample) |
| ZA (1) | ZA200903689B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000015273A1 (de) | 1998-09-11 | 2000-03-23 | Gerhard Schmidmaier | Biologisch aktive implantate |
| US20100226956A1 (en) * | 2009-03-06 | 2010-09-09 | Per Kjellin | Production of moldable bone substitute |
| US9358323B2 (en) * | 2010-04-29 | 2016-06-07 | Warsaw Orthopedic, Inc. | Flowable ceramic putty |
| NL2011195C2 (en) | 2013-07-18 | 2015-01-21 | Xpand Biotechnology B V | Method for producing an osteoinductive calcium phosphate and products thus obtained. |
| US10682442B2 (en) | 2014-04-04 | 2020-06-16 | University Of Kentucky Research Foundation | Small molecule drug release from in situ forming degradable scaffolds incorporating hydrogels and bioceramic microparticles |
| WO2016035751A1 (ja) * | 2014-09-01 | 2016-03-10 | 国立大学法人九州大学 | 製品無機化合物の製造方法及び製品無機化合物 |
| WO2016140626A1 (en) * | 2015-03-04 | 2016-09-09 | Agency For Science, Technology And Research | Composite material for drug delivery |
| US20220249735A1 (en) * | 2019-08-31 | 2022-08-11 | Shenzhen Corliber Scientific Co., Ltd. | Mouldable artificial bone composite material and preparation method thereof |
| CN111110929B (zh) * | 2020-02-15 | 2020-12-22 | 深圳脉动医学技术有限公司 | 一种高生物安全性心脏支架及其制造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6926903B2 (en) * | 2001-12-04 | 2005-08-09 | Inion Ltd. | Resorbable polymer composition, implant and method of making implant |
| GB0302026D0 (en) * | 2003-01-29 | 2003-02-26 | Biocomposites Ltd | Bioabsorbable implant |
| MXPA05008653A (es) * | 2003-02-14 | 2006-04-27 | Depuy Spine Inc | Dispositivo de fusion intervertebral formado in situ. |
| EP1778760A4 (en) * | 2004-07-30 | 2009-01-21 | Univ Nebraska | BIOREGRADABLE COMPOSITES AND METHOD FOR FORMING THE SAME |
-
2007
- 2007-10-31 BR BRPI0718068-3A2A patent/BRPI0718068A2/pt not_active IP Right Cessation
- 2007-10-31 US US12/447,959 patent/US20100041770A1/en not_active Abandoned
- 2007-10-31 JP JP2009534709A patent/JP2010508071A/ja not_active Withdrawn
- 2007-10-31 KR KR1020097009947A patent/KR20090091710A/ko not_active Withdrawn
- 2007-10-31 EP EP07867330A patent/EP2086604A2/en not_active Withdrawn
- 2007-10-31 CN CNA2007800445770A patent/CN101600462A/zh active Pending
- 2007-10-31 AU AU2007314268A patent/AU2007314268A1/en not_active Abandoned
- 2007-10-31 CA CA002668265A patent/CA2668265A1/en not_active Abandoned
- 2007-10-31 WO PCT/US2007/023014 patent/WO2008054794A2/en not_active Ceased
-
2009
- 2009-05-27 ZA ZA200903689A patent/ZA200903689B/xx unknown
- 2009-05-28 CO CO09054994A patent/CO6190540A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010508071A5 (enExample) | ||
| US20220354956A1 (en) | Biodegradable drug delivery for hydrophobic compositions | |
| CN103491946B (zh) | 可生物降解的药物释放组合物 | |
| PE20040675A1 (es) | Formulaciones de deposito de liberacion controlada | |
| CA2348016C (en) | Controlled release liquid delivery compositions with low initial drug burst | |
| CA2714757C (en) | Low viscosity liquid polymeric delivery system | |
| JP7210816B6 (ja) | 医薬組成物 | |
| EP0436667B1 (en) | Biodegradable in-situ forming implants | |
| US8501230B2 (en) | Self solidifying bioerodible barrier implant | |
| Qin et al. | Formulation and evaluation of in situ forming PLA implant containing tinidazole for the treatment of periodontitis | |
| PT1781264E (pt) | Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma | |
| RU2012157244A (ru) | Жидкотекучие композиции для инъекций, включающие бупренорфин | |
| JP2004510807A5 (enExample) | ||
| CA2468703A1 (en) | Controlled release polymeric compositions of bone growth promoting compounds | |
| Dunn | The atrigel drug delivery system | |
| Wan et al. | Investigating a new drug delivery nano composite membrane system based on PVA/PCL and PVA/HA (PEG) for the controlled release of biopharmaceuticals for bone infections | |
| US20100041770A1 (en) | Polymer-ceramic composite and method | |
| BR112020011774A2 (pt) | composições farmacêuticas com duração de liberação selecionada | |
| Babasola et al. | Osmotic pressure driven protein release from viscous liquid, hydrophobic polymers based on 5-ethylene ketal ε-caprolactone: potential and mechanism | |
| Amsden et al. | Synthesis and characterization of biodegradable networks providing saturated-solution prolonged delivery | |
| Lazaridou | Synthesis and study of novel modified chitosan hydrogels for controlled drug delivery | |
| US12214105B2 (en) | Long lasting biodegradable polymer based in-situ forming implant for treatment of bone injuries | |
| JP2003155404A (ja) | 抗菌剤・高分子複合物及びその製造方法 | |
| TW201909887A (zh) | 藥物載體及其應用之藥物傳遞系統 |